Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
shingles
Biotech
Curevo clinches $110M, nabs Moncef Slaoui to lead board
The biotech wants to take on Shingrix with an assist from GSK vet and Operation Warp Speed chief scientific advisor Moncef Slaoui, Ph.D.
Gabrielle Masson
Mar 17, 2025 10:44am
Moderna touts 3 phase 1 data sets to bolster early vax work
Mar 27, 2024 3:21pm
Curevo’s shingles vaccine equals Shingrix in ph. 2 head-to-head
Jan 8, 2024 9:44am
Curevo will go head-to-head against GSK's Shingrix with $60M
Feb 10, 2022 11:25am
Pfizer, BioNTech team up against GSK's Shingrix dominance
Jan 5, 2022 9:49am
Xenon’s Teva-partnered pain drug flunks another test
Jun 27, 2017 10:14am
